医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Mannatech Hosts Annual Australasian Convention

2013年10月18日 AM01:25
このエントリーをはてなブックマークに追加


 

COPPELL, Texas

Mannatech®, Incorporated (NASDAQ: MTEX), the founder of the Mission 5 MillionSM social entrepreneurial movement and leading innovator of naturally-sourced supplements based on Real Food Technology® solutions, hosts its annual Australasian Convention at the Adelaide Entertainment Center, in Adelaide, Australia, October 18-20, 2013, for independent sales Associates and members from Australia, New Zealand and Singapore.

The Australasian Convention (ACON) runs for three days and features panel discussions, workshops and fun. Associates will learn and be inspired by forward-thinking speakers on the topics of product innovation, business growth, social entrepreneurship and personal growth. Founder Sam Caster will address why Mannatech is the force of the future and leading the way with the Mission 5 Million℠, M5M℠, movement. Senior Wellness Director, Dr. Steve Nugent, will share his expertise about vitamins and supplements, and the importance of nutrition in our diets. Roy Truett, Chief Operating Officer and President of International Operations, will talk about market expansion. Platinum Presidential, Rodney Gilchrist, will present a call to action for Associates worldwide to share M5M. And Don Partridge, Platinum Presidential Director and educator on glyconutrients, will be a presenter.

Gold medal paralympian Matt Levy will be sharing how Mannatech’s products spurred his sports performance. Singer Rachael Leahcar, a finalist on the American reality television broadcast, The Voice, will perform. She sings in Italian, French and Spanish and plays piano and flute.

The convention will celebrate Mannatech’s top business builders with an awards ceremony Friday, October 18, along with announcements of the Mike Forrest Giving Spirit Award, the Leadership Development Award, the Top Enroller of the Year Award, the Top Income Earner of the Year Award, and The Associate of the Year Award.

Mannatech opened its doors in Australia in 1998, New Zealand in 2002 and Singapore in 2008. Today, Mannatech’s products are sold in 24 countries.

Learn more about the 2013 Australasian Convention: http://www.mannatech.com.au/acon2013/. To learn more about Mannatech and its Mission 5 Million movement, visit Mannatech.com.

About Mannatech

Mannatech, Incorporated, develops high-quality health, weight and fitness, and skin care products that are based on the solid foundation of nutritional science and development standards. Mannatech is dedicated to its platform of Social Entrepreneurship based on the foundation of promoting, aiding and optimizing nutrition where it is needed most around the world. Mannatech’s proprietary products are available through independent sales Associates around the globe including the United States, Canada, South Africa, Australia, New Zealand, Austria, Denmark, Germany, Norway, Sweden, the Netherlands, the United Kingdom, Japan, Taiwan, Singapore, Estonia, Finland, the Republic of Ireland, Czech Republic, the Republic of Korea, Mexico, Namibia, Hong Kong and Ukraine. For more information, visit Mannatech.com.

Please note: This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as “believe,” “intend” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties and other factors. Some of these factors include, among others, Mannatech’s inability to attract and retain Associates and Members, increases in competition, litigation, regulatory changes and its planned growth into new international markets. Although Mannatech believes that the expectations, statements and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.

CONTACT

Mannatech, Incorporated
Brett Duncan, 972-471-7367
bduncan@mannatech.com

同じカテゴリーの記事 

  • La Jolla Institute for Immunology and RevolKa started a Research Collaboration
  • U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
  • ESCMID Global 2024: Shionogi presents real-world data demonstrating efficacy of Fetcroja® / Fetroja® (cefiderocol) in critically ill patients with certain difficult-to-treat bacterial infections
  • Renesas’ New FemtoClock™ 3 Timing Solution Delivers Industry’s Lowest Power and Leading Jitter Performance of 25fs-rms
  • 成人向け予防接種プログラムは初期投資の19倍もの社会経済的価値をもたらすとの新レポートを発表